These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 24842180)
1. Intrathecal injection of the peptide myr-NR2B9c attenuates bone cancer pain via perturbing N-methyl-D-aspartate receptor-PSD-95 protein interactions in mice. Liu Y; Cui X; Sun YE; Yang X; Ni K; Zhou Y; Ma Z; Gu X Anesth Analg; 2014 Jun; 118(6):1345-54. PubMed ID: 24842180 [TBL] [Abstract][Full Text] [Related]
2. Perturbing NR2B-PSD-95 interaction relieves neuropathic pain by inactivating CaMKII-CREB signaling. Xu F; Zhao X; Liu L; Song J; Zhu Y; Chu S; Shao X; Li X; Ma Z; Gu X Neuroreport; 2017 Sep; 28(13):856-863. PubMed ID: 28746067 [TBL] [Abstract][Full Text] [Related]
3. Intrathecal injection of selected peptide Myr-RC-13 attenuates bone cancer pain by inhibiting KIF17 and NR2B expression. Ni K; Zhou Y; Sun YE; Liu Y; Gu XP; Ma ZL Pharmacol Biochem Behav; 2014 Jul; 122():228-33. PubMed ID: 24726705 [TBL] [Abstract][Full Text] [Related]
4. Intrathecal administration of the cannabinoid 2 receptor agonist JWH015 can attenuate cancer pain and decrease mRNA expression of the 2B subunit of N-methyl-D-aspartic acid. Gu X; Mei F; Liu Y; Zhang R; Zhang J; Ma Z Anesth Analg; 2011 Aug; 113(2):405-11. PubMed ID: 21519057 [TBL] [Abstract][Full Text] [Related]
5. The role of N-methyl-D-aspartate receptor subunit NR2B in spinal cord in cancer pain. Gu X; Zhang J; Ma Z; Wang J; Zhou X; Jin Y; Xia X; Gao Q; Mei F Eur J Pain; 2010 May; 14(5):496-502. PubMed ID: 19815434 [TBL] [Abstract][Full Text] [Related]
6. CREB-regulated transcription coactivator 1 enhances CREB-dependent gene expression in spinal cord to maintain the bone cancer pain in mice. Liang Y; Liu Y; Hou B; Zhang W; Liu M; Sun YE; Ma Z; Gu X Mol Pain; 2016; 12():. PubMed ID: 27060162 [TBL] [Abstract][Full Text] [Related]
7. The inhibitor of calcium/calmodulin-dependent protein kinase II KN93 attenuates bone cancer pain via inhibition of KIF17/NR2B trafficking in mice. Liu Y; Liang Y; Hou B; Liu M; Yang X; Liu C; Zhang J; Zhang W; Ma Z; Gu X Pharmacol Biochem Behav; 2014 Sep; 124():19-26. PubMed ID: 24836181 [TBL] [Abstract][Full Text] [Related]
8. Amitriptyline attenuates astrocyte activation and morphine tolerance in rats: role of the PSD-95/NR1/nNOS/PKCĪ³ signaling pathway. Huang YN; Tsai RY; Lin SL; Chien CC; Cherng CH; Wu CT; Yeh CC; Wong CS Behav Brain Res; 2012 Apr; 229(2):401-11. PubMed ID: 22309983 [TBL] [Abstract][Full Text] [Related]
9. Analgesic Effect of Intrathecal Administration of Chemokine Receptor CCR2 Antagonist is Related to Change in Spinal NR2B, nNOS, and SIGIRR Expression in Rat with Bone Cancer Pain. Ren F; Jiao H; Cai H Cell Biochem Biophys; 2015 Jun; 72(2):611-6. PubMed ID: 25653100 [TBL] [Abstract][Full Text] [Related]
10. NR2B phosphorylation at tyrosine 1472 in spinal dorsal horn contributed to N-methyl-D-aspartate-induced pain hypersensitivity in mice. Li S; Cao J; Yang X; Suo ZW; Shi L; Liu YN; Yang HB; Hu XD J Neurosci Res; 2011 Nov; 89(11):1869-76. PubMed ID: 21800351 [TBL] [Abstract][Full Text] [Related]
11. Intrathecal administration of roscovitine attenuates cancer pain and inhibits the expression of NMDA receptor 2B subunit mRNA. Zhang R; Liu Y; Zhang J; Zheng Y; Gu X; Ma Z Pharmacol Biochem Behav; 2012 Jul; 102(1):139-45. PubMed ID: 22503970 [TBL] [Abstract][Full Text] [Related]
13. Intrathecal injection of metabotropic glutamate receptor subtype 3 and 5 agonist/antagonist attenuates bone cancer pain by inhibition of spinal astrocyte activation in a mouse model. Ren BX; Gu XP; Zheng YG; Liu CL; Wang D; Sun YE; Ma ZL Anesthesiology; 2012 Jan; 116(1):122-32. PubMed ID: 22123524 [TBL] [Abstract][Full Text] [Related]
14. Intrathecal administration of roscovitine prevents remifentanil-induced postoperative hyperalgesia and decreases the phosphorylation of N-methyl-D-aspartate receptor and metabotropic glutamate receptor 5 in spinal cord. Liu X; Liu Y; Zhang J; Zhang W; Sun YE; Gu X; Ma Z Brain Res Bull; 2014 Jul; 106():9-16. PubMed ID: 24769228 [TBL] [Abstract][Full Text] [Related]
15. Involvement of the spinal NMDA receptor/PKCĪ³ signaling pathway in the development of bone cancer pain. Xiaoping G; Xiaofang Z; Yaguo Z; Juan Z; Junhua W; Zhengliang M Brain Res; 2010 Jun; 1335():83-90. PubMed ID: 20362561 [TBL] [Abstract][Full Text] [Related]
16. Role of nitric oxide synthase in the development of bone cancer pain and effect of L-NMMA. Yang Y; Zhang J; Liu Y; Zheng Y; Bo J; Zhou X; Wang J; Ma Z Mol Med Rep; 2016 Feb; 13(2):1220-6. PubMed ID: 26648027 [TBL] [Abstract][Full Text] [Related]
17. N-methyl-D-aspartate receptor subunit- and neuronal-type dependence of excitotoxic signaling through post-synaptic density 95. Fan J; Vasuta OC; Zhang LY; Wang L; George A; Raymond LA J Neurochem; 2010 Nov; 115(4):1045-56. PubMed ID: 20831617 [TBL] [Abstract][Full Text] [Related]
18. Activation of GRs-Akt-nNOs-NR2B signaling pathway by second dose GR agonist contributes to exacerbated hyperalgesia in a rat model of radicular pain. Zhang J; Zhang W; Sun Y; Liu Y; Song L; Ma Z; Gu X Mol Biol Rep; 2014 Jun; 41(6):4053-61. PubMed ID: 24562683 [TBL] [Abstract][Full Text] [Related]